It is not quite a 15 member board - some of those 15 are actually staff e.g. product development, research, operations etc
http://www.biotapharma.com/?page=1021000&subpage=1021167
However, in saying all this, what does, for example, Leigh Farrell do in "Business Development" - I'm just picking his name as an example, on the basis of his title.
As shareholders, we are also owners. We have a right to ask the Board to justify the role of each and every Board Member as well as Senior Staff Members. With the arrival of our new dynamic duo Pres and VP, surely they can also earmark some senior executive and Board dead wood, or to put it nicely, some personnel whose roles might now overlap with others and therefore justify "the chop".
- Forums
- ASX - By Stock
- BTA
- strategic review out
strategic review out , page-24
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online